Seeing Is Believing
INVO is currently covered by 1 analysts with an average price target of $1.91. This is a potential upside of $1.19 (165.28%) from yesterday's end of day stock price of $0.72.
INVO Bioscience's activity chart (see below) currently has 4 price targets and 4 ratings on display. The stock rating distribution of INVO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 18 days.
Highest price target for INVO is $1, Lowest price target is $1, average price target is $1.91.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 16-Aug-2023. First documented stock forecast 29-Dec-2020.
Currently out of the existing stock ratings of INVO, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$3.93 (367.29%)
$140
1 years 5 months 26 days ago
(16-Aug-2023)
0/2 (0%)
$3.58 (252.11%)
Buy
$40
$38.93 (3638.32%)
$115
2 years 9 months 29 days ago
(13-Apr-2022)
2/2 (100%)
$-1.2 (-2.91%)
36
What is INVO (INVO Bioscience) average time for price targets to be met?
Which analyst has the current highest performing score on INVO (INVO Bioscience) with a proven track record?
Which analyst has the current lower performing score on INVO (INVO Bioscience) with a proven track record?
Which analyst has the most public recommendations on INVO (INVO Bioscience)?
Which analyst is the currently most bullish on INVO (INVO Bioscience)?
Which analyst is the currently most reserved on INVO (INVO Bioscience)?